Ultragenyx Pharmaceutical, Inc. (RARE)
14.30
-0.10
(-0.69%)
USD |
NASDAQ |
Sep 11, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Liabilities (Quarterly) : 1.548B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.548B |
| March 31, 2026 | 1.525B |
| December 31, 2025 | 1.605B |
| September 30, 2025 | 1.174B |
| June 30, 2025 | 1.148B |
| March 31, 2025 | 1.161B |
| December 31, 2024 | 1.241B |
| September 30, 2024 | 1.185B |
| June 30, 2024 | 1.186B |
| March 31, 2024 | 1.167B |
| December 31, 2023 | 1.222B |
| September 30, 2023 | 1.206B |
| June 30, 2023 | 1.182B |
| March 31, 2023 | 1.163B |
| December 31, 2022 | 1.199B |
| September 30, 2022 | 1.150B |
| June 30, 2022 | 642.55M |
| March 31, 2022 | 587.60M |
| December 31, 2021 | 608.78M |
| September 30, 2021 | 551.13M |
| June 30, 2021 | 540.27M |
| March 31, 2021 | 543.18M |
| December 31, 2020 | 638.53M |
| September 30, 2020 | 602.19M |
| June 30, 2020 | 618.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 623.99M |
| December 31, 2019 | 489.39M |
| September 30, 2019 | 152.68M |
| June 30, 2019 | 139.14M |
| March 31, 2019 | 121.03M |
| December 31, 2018 | 110.65M |
| September 30, 2018 | 102.55M |
| June 30, 2018 | 102.05M |
| March 31, 2018 | 93.69M |
| December 31, 2017 | 107.30M |
| September 30, 2017 | 69.49M |
| June 30, 2017 | 68.09M |
| March 31, 2017 | 57.34M |
| December 31, 2016 | 66.65M |
| September 30, 2016 | 59.28M |
| June 30, 2016 | 38.06M |
| March 31, 2016 | 34.36M |
| December 31, 2015 | 28.48M |
| September 30, 2015 | 25.37M |
| June 30, 2015 | 23.73M |
| March 31, 2015 | 14.72M |
| December 31, 2014 | 13.02M |
| September 30, 2014 | 11.60M |
| June 30, 2014 | 9.503M |
| March 31, 2014 | 6.993M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 141.00B |
| Biogen, Inc. | 13.24B |
| BioMarin Pharmaceutical, Inc. | 5.402B |
| Ionis Pharmaceuticals, Inc. | 2.555B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.264B |
| Shareholders Equity (Quarterly) | -291.00M |
| Debt to Equity Ratio | -4.131 |
| Current Ratio | 1.726 |
| Net Debt Paydown Yield | -1.90% |